Counterweight Ventures LLC Grows Position in iShares Biotechnology ETF (NASDAQ:IBB)

Counterweight Ventures LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,761 shares of the financial services provider’s stock after acquiring an additional 245 shares during the quarter. Counterweight Ventures LLC’s holdings in iShares Biotechnology ETF were worth $791,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets boosted its position in iShares Biotechnology ETF by 25.7% during the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock worth $282,038,000 after purchasing an additional 420,053 shares in the last quarter. Global Assets Advisory LLC purchased a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth about $66,059,000. Raymond James Financial Services Advisors Inc. grew its stake in iShares Biotechnology ETF by 24.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after acquiring an additional 42,822 shares during the last quarter. Commonwealth Equity Services LLC increased its holdings in iShares Biotechnology ETF by 5.3% during the 1st quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock valued at $27,267,000 after acquiring an additional 10,033 shares in the last quarter. Finally, Raymond James & Associates raised its position in iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after acquiring an additional 7,931 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.4 %

IBB stock opened at $142.75 on Friday. The company’s 50 day simple moving average is $144.12 and its 200-day simple moving average is $138.01. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.17.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.